Imogen Fitt[email protected]HomeWhy best-of-breed LIS vendors might yet survive EHR’s invasionIs EHR-based LIS therefore a foregone conclusion? Or is there a place still for dedicated BoB-LIS? Based on our latest research assessing the global LIS market, the evidence points to a surprisingly bright future for BoB-LIS.May 30, 2022Pathology, histologyDigital pathology: What does the future hold?There are unique circumstances causing this, including a combination of overregulation, tight reimbursement, and a lack of evidence for tangible cost savings. However, even despite this, pathology's dwindling workforce and increasing caseloads have always made the case for digitization's seeming inevitability.Table 1: Digital pathology drivers and barriers. 1= Least important, 10 = Most important.Table 1: Digital pathology drivers and barriers. 1= Least important, 10 = Most important.December 20, 2021Artificial IntelligenceVenture capital funding for digital pathology tops $860MInvestment is now evolving to focus on startups developing artificial intelligence (AI) solutions for digital pathology image analysis.Image courtesy of Signify.Image courtesy of SignifyApril 26, 2021Page 1 of 1Top StoriesValidationImmunovia announces positive results for next-gen pancreatic cancer testDiagnostics company Immunovia announced positive results for the newest generation of its pancreatic cancer test from a model-development study, announcing that the test achieved both its primary and secondary endpoints.CollaborationVertex to pay $25M upfront to scale cell manufacturing technologyFinancial ResultsBristol Myers Squibb to reduce workforce in restructuring planLawsuitU.K. Patents Court rules Bio-Techne patents invalid in infringement lawsuitSponsor ContentVisit our Molecular Diagnostics Community
